Home

פאנל איזה מהם מצרים mog antibody סטטיסטי רכישה תפוז

Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease:  practical considerations | Practical Neurology
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations | Practical Neurology

MOG antibody disease: A review of MOG antibody seropositive neuromyelitis  optica spectrum disorder - Multiple Sclerosis and Related Disorders
MOG antibody disease: A review of MOG antibody seropositive neuromyelitis optica spectrum disorder - Multiple Sclerosis and Related Disorders

Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease:  practical considerations | Practical Neurology
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations | Practical Neurology

Myelin-oligodendrocyte glycoprotein antibody-associated disease - The  Lancet Neurology
Myelin-oligodendrocyte glycoprotein antibody-associated disease - The Lancet Neurology

Neuropathology of MOG-antibody–associated demyelination | Download  Scientific Diagram
Neuropathology of MOG-antibody–associated demyelination | Download Scientific Diagram

IJMS | Free Full-Text | Cells to the Rescue: Emerging Cell-Based Treatment  Approaches for NMOSD and MOGAD | HTML
IJMS | Free Full-Text | Cells to the Rescue: Emerging Cell-Based Treatment Approaches for NMOSD and MOGAD | HTML

Figure 1 from Defining distinct features of anti-MOG antibody associated  central nervous system demyelination | Semantic Scholar
Figure 1 from Defining distinct features of anti-MOG antibody associated central nervous system demyelination | Semantic Scholar

Overview of patient cohort, antibody status, and anti-MOG antibody... |  Download Scientific Diagram
Overview of patient cohort, antibody status, and anti-MOG antibody... | Download Scientific Diagram

Neurological update: MOG antibody disease | SpringerLink
Neurological update: MOG antibody disease | SpringerLink

MOG antibody demyelination | Great Ormond Street Hospital
MOG antibody demyelination | Great Ormond Street Hospital

Frontiers | Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Positive  Patients in a Multi-Ethnic Canadian Cohort
Frontiers | Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Positive Patients in a Multi-Ethnic Canadian Cohort

Overview of patient cohort, antibody status, and anti-MOG antibody... |  Download Scientific Diagram
Overview of patient cohort, antibody status, and anti-MOG antibody... | Download Scientific Diagram

Clinicoradiological comparative study of Aquaporin-4-IgG seropositive  neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated  disease (MOGAD): A prospective observational study and review of literature  - ScienceDirect
Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature - ScienceDirect

Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease:  practical considerations | Practical Neurology
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations | Practical Neurology

The spectrum of MOG autoantibody-associated demyelinating diseases | Nature  Reviews Neurology
The spectrum of MOG autoantibody-associated demyelinating diseases | Nature Reviews Neurology

Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein  antibodies in pediatric monophasic demyelinating diseases and multiple  sclerosis - ScienceDirect
Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis - ScienceDirect

COVID-19, HHV6 and MOG antibody: A perfect storm - Journal of  Neuroimmunology
COVID-19, HHV6 and MOG antibody: A perfect storm - Journal of Neuroimmunology

Pathology of myelin oligodendrocyte glycoprotein antibody–associated  disease - Misu - 2021 - Clinical and Experimental Neuroimmunology - Wiley  Online Library
Pathology of myelin oligodendrocyte glycoprotein antibody–associated disease - Misu - 2021 - Clinical and Experimental Neuroimmunology - Wiley Online Library

Frontiers | MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis:  Lessons Learned From Neuromyelitis Optica Spectrum Disorder
Frontiers | MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder

Overlapping autoimmune syndrome: A case of concomitant anti-NMDAR  encephalitis and myelin oligodendrocyte glycoprotein (MOG) antibody disease  - ScienceDirect
Overlapping autoimmune syndrome: A case of concomitant anti-NMDAR encephalitis and myelin oligodendrocyte glycoprotein (MOG) antibody disease - ScienceDirect

A multicenter comparison of MOG-IgG cell-based assays | Neurology
A multicenter comparison of MOG-IgG cell-based assays | Neurology

The pathological features of MOG antibody-positive cerebral cortical  encephalitis as a new spectrum associated with MOG antibodies: A case  report - Journal of the Neurological Sciences
The pathological features of MOG antibody-positive cerebral cortical encephalitis as a new spectrum associated with MOG antibodies: A case report - Journal of the Neurological Sciences

Anti-MOG antibody [C2C3], C-term (GTX106283) | GeneTex
Anti-MOG antibody [C2C3], C-term (GTX106283) | GeneTex

MOG antibody disease manifesting as progressive cognitive deterioration and  behavioral changes with primary central nervous system vasculitis -  Multiple Sclerosis and Related Disorders
MOG antibody disease manifesting as progressive cognitive deterioration and behavioral changes with primary central nervous system vasculitis - Multiple Sclerosis and Related Disorders

2018 RNDS — MOG Antibody-Associated Disease - YouTube
2018 RNDS — MOG Antibody-Associated Disease - YouTube

What is MOGAD? | MOG Antibody Disease | SRNA
What is MOGAD? | MOG Antibody Disease | SRNA

Selective Depletion of Antigen-Specific Antibodies for the Treatment of  Demyelinating Disease - ScienceDirect
Selective Depletion of Antigen-Specific Antibodies for the Treatment of Demyelinating Disease - ScienceDirect